Janus Henderson Group Portfolio holdings
Janus Henderson Group, formed in 2017 through the merger of Janus Capital Group (founded 1969) and Henderson Group (founded 1934), is a global asset management firm headquartered in London, managing over $350 billion in assets as of late 2024 for institutional, retail, and high-net-worth clients. With a strong presence in the U.S., Europe, and Asia-Pacific, the firm offers a wide range of investment products, including equities, fixed income, multi-asset, and alternative strategies, often blending active management with research-driven insights. Known for its equity expertise from Janus’s growth-focused heritage and Henderson’s European fixed-income strengths, Janus Henderson serves clients through mutual funds, ETFs, and bespoke portfolios, emphasizing risk-adjusted returns and ESG integration. Led by CEO Ali Dibadj since 2022, the publicly traded firm (NYSE: JHG) continues to refine its strategy amid competitive pressures, maintaining a foothold in key markets worldwide.
Top Buys
| 1 |
NVIDIA
NVDA
|
$549M |
| 2 |
Chipotle Mexican Grill
CMG
|
$467M |
| 3 |
Boeing
BA
|
$441M |
| 4 |
Broadcom
AVGO
|
$350M |
| 5 |
CoStar Group
CSGP
|
$320M |
Top Sells
| 1 |
Alphabet (Google) Class C
GOOG
|
$1.62B |
| 2 |
Progressive
PGR
|
$570M |
| 3 |
ASML
ASML
|
$562M |
| 4 |
Mastercard
MA
|
$313M |
| 5 |
Johnson & Johnson
JNJ
|
$300M |
Sector Composition
| 1 | Technology | 36.63% |
| 2 | Healthcare | 15.9% |
| 3 | Consumer Discretionary | 10.83% |
| 4 | Financials | 10.24% |
| 5 | Industrials | 8.92% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
251
Walker & Dunlop
WD
$2.83B
| $110M | 0.05% |
1,559,135
-301,643
| -16% | -$21.3M |
|
252
Blackbaud
BLKB
$3.19B
| $109M | 0.05% |
1,695,089
-426,149
| -20% | -$27.4M |
|
253
Ziff Davis
ZD
$1.56B
| $108M | 0.05% |
3,568,911
+26,941
| +0.8% | +$816K |
|
254
Praxis Precision Medicines
PRAX
$946M
| $107M | 0.05% |
2,533,405
+1,026,969
| +68% | +$43.2M |
|
255
CACI
CACI
$10.6B
| $105M | 0.05% |
220,702
-8,214
| -4% | -$3.92M |
|
256
Arista Networks
ANET
$171B
| $104M | 0.05% |
1,018,121
+43,688
| +4% | +$4.47M |
|
257
Janux Therapeutics
JANX
$1.37B
| $103M | 0.05% |
4,460,332
-137,760
| -3% | -$3.18M |
|
258
Elevance Health
ELV
$72.6B
| $103M | 0.05% |
264,664
-8,108
| -3% | -$3.15M |
|
259
Jabil
JBL
$21.7B
| $103M | 0.05% |
472,074
+195,753
| +71% | +$42.7M |
|
260
Keysight
KEYS
$28.1B
| $102M | 0.05% |
620,778
-26,314
| -4% | -$4.31M |
|
261
Builders FirstSource
BLDR
$15.2B
| $100M | 0.05% |
859,258
+441,808
| +106% | +$51.6M |
|
262
Bank of America
BAC
$373B
| $99.7M | 0.05% |
2,107,472
+180,760
| +9% | +$8.55M |
|
|
AVDL
263
Avadel Pharmaceuticals
AVDL
$1.45B
| $98.5M | 0.05% |
11,132,131
-2,460,203
| -18% | -$21.8M |
|
264
Crinetics Pharmaceuticals
CRNX
$3.14B
| $98.1M | 0.05% |
3,410,320
-14,122
| -0.4% | -$406K |
|
265
Guidewire Software
GWRE
$18.3B
| $97.6M | 0.05% |
414,955
-202,305
| -33% | -$47.6M |
|
266
Neurocrine Biosciences
NBIX
$14.1B
| $97.5M | 0.05% |
776,070
-7,896
| -1% | -$992K |
|
267
Stantec
STN
$12.3B
| $97.5M | 0.05% |
890,975
-41,655
| -4% | -$4.56M |
|
268
Saia
SAIA
$7.79B
| $97.4M | 0.05% |
355,623
+109,666
| +45% | +$30M |
|
269
Alibaba
BABA
$330B
| $96.4M | 0.05% |
850,500
-2,082,374
| -71% | -$236M |
|
|
MTSR
270
Metsera, Inc. Common Stock
MTSR
$3.8B
| $96.4M | 0.05% |
3,387,963
+482,501
| +17% | +$13.7M |
|
271
Agree Realty
ADC
$7.99B
| $95.3M | 0.05% |
1,303,908
+505,251
| +63% | +$36.9M |
|
272
Coca-Cola
KO
$297B
| $95.2M | 0.05% |
1,346,715
-252,852
| -16% | -$17.9M |
|
273
Structure Therapeutics
GPCR
$1.16B
| $94.9M | 0.05% |
4,573,006
+217,812
| +5% | +$4.52M |
|
274
Doximity
DOCS
$12.5B
| $94.9M | 0.05% |
1,546,830
+107,299
| +7% | +$6.58M |
|
275
Monolithic Power Systems
MPWR
$39.4B
| $93.2M | 0.05% |
127,429
+21,816
| +21% | +$16M |
|